Last reviewed · How we verify

curcumin paste

Ain Shams University · FDA-approved active Small molecule

Curcumin is a polyphenolic compound that exerts anti-inflammatory and antioxidant effects by inhibiting multiple signaling pathways including NF-κB and reducing reactive oxygen species.

Curcumin is a polyphenolic compound that exerts anti-inflammatory and antioxidant effects by inhibiting multiple signaling pathways including NF-κB and reducing reactive oxygen species. Used for Inflammatory conditions (general), Antioxidant support.

At a glance

Generic namecurcumin paste
SponsorAin Shams University
Drug classNatural product/polyphenol
TargetNF-κB, multiple targets (non-selective)
ModalitySmall molecule
Therapeutic areaAnti-inflammatory/Antioxidant
PhaseFDA-approved

Mechanism of action

Curcumin, the active constituent of turmeric, modulates inflammatory mediators and transcription factors involved in chronic disease pathogenesis. It acts as a free radical scavenger and suppresses pro-inflammatory cytokine production, making it relevant for conditions characterized by chronic inflammation and oxidative stress.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: